Compounds > orantinib
Page last updated: 2024-09-05

orantinib and y 27632

orantinib has been researched along with y 27632 in 1 studies

Compound Research Comparison

Studies
(orantinib)		Trials
(orantinib)		Recent Studies (post-2010)
(orantinib)		Studies
(y 27632)		Trials
(y 27632)		Recent Studies (post-2010) (y 27632)
11019361,9243891

Protein Interaction Comparison

ProteinTaxonomyorantinib (IC50)y 27632 (IC50)
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunitBos taurus (cattle)6
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunitBos taurus (cattle)6
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunitBos taurus (cattle)6
Chain I, cAMP-dependent protein kinase inhibitor alphasynthetic construct6
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunitBos taurus (cattle)6
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunitBos taurus (cattle)6
Chain I, cAMP-dependent protein kinase inhibitor alphasynthetic construct6
Rho-associated protein kinase 2Homo sapiens (human)0.1942
Ribosomal protein S6 kinase alpha-5Homo sapiens (human)8.3
cAMP-dependent protein kinase catalytic subunit alphaBos taurus (cattle)6.1
C-C motif chemokine 2Homo sapiens (human)2.6303
Rho-associated protein kinase 1Homo sapiens (human)0.3713
Serine/threonine-protein kinase N2Homo sapiens (human)0.6
Rho-associated protein kinase 2Bos taurus (cattle)6.1
Rho-associated protein kinase 2Rattus norvegicus (Norway rat)0.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N1

Other Studies

1 other study(ies) available for orantinib and y 27632

ArticleYear
The selectivity of protein kinase inhibitors: a further update.
    The Biochemical journal, 2007, Dec-15, Volume: 408, Issue:3

    Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera

2007